Đánh giá hiệu quả hạ huyết áp và khả năng dung nạp của Lercanidipine so với Amlodipine ở bệnh nhân nhồi máu não có tăng huyết áp bằng huyết áp lưu động 24 giờ
Tóm tắt
Đánh giá hiệu quả hạ huyết áp và khả năng dung nạp của Lercanidipine so với Amlodipine ở bệnh nhân nhồi máu não có tăng huyết áp bằng huyết áp lưu động 24 giờTài liệu tham khảo
1. Harold P. Adams, Lawrence Brass, Anthony Furlan et al (2007), Guidelines for the Early Management of Adults With Ischemic Stroke, AHA/ASA Guidelines, p 1655-1693.
2. Vivencio Barrios et al (2002), Antihypertension Efficacy and Tolerability of Lercanidipine in Daily Clinical Practice. The ELYPSE Study, Blood Pressure 2002, Vol 11, p 95-100.
3. Barrios et al (2006), Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA Study, Journal Clinical Practice, 60,11:1364-1370
4. Norm Campbell et al (2010), Canadian Hypertension Education Program recommendations, An annual update, Canadian Family Physician- Le Medecin de famille canadien, p 649-653.
5. Campo et al (2005), Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patient, Minerva Med, 96 (5): 365-371.
6. Flack J.M, Nasser SA (2011), Benefits of once-daily therapies in the treatmment of hypertension, Vase Health Risk Manag 2011; 7:777-787
7. Goda. A et al (2010), Comparative effects of lercanidipine and amlodipine in treatment of mild to moderate hypertension, Journal of Hypertension, vol 28, e-Supplement A, p 277-278.
8. Hernandez RH and al (2001), Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses, Blood Press Monit 2001, 6(1):47-57.
9. Iqbal. P and Louise Stevension (2011), Cardiovascular Outcomes in patients with normal and abnormal 24-hour ambulatory blood pressure monitoring, International Journal of Hypertension, 4 pages.
10. Yuan Jiao et al(2012), Reduction of the morning blood pressure surge treated with Olmesartan in Chinese patients with mild to moderate essential hypertension- a multicenter, open-label, single treatment group clinical study, European Review for Medical and Pharmacological Sciences, 16: 653-659.
11. Gastone Leonetti et al (2002), Tolerability of Long- Term Treatment With Lercanidipine Versus Amlodipine and Lacidipine in Elderly Hypertensives, American Journal of Hypertension, Vol 15, p 932-940.
12. Joel M. Neutel and David H.G. Smith (2003), Evaluation of Angiotensin II Receptor Blockers for 24- Hour Blood Pressure Control: Meta- Analysis of a Clinical Database, the journal of hypertension; Vol V, No 1: 58-63
13. Omboni S, Zanchetti A (1998), Antihypertension efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensive assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators, Journal Hypertens 1998, 16:1831-1838.
14. Narakin Sansanayudh et al (2010), Comparison of Changes of Body Water Measured by Using Bioelectrical Impedance Analysis between Lercanidipine and Amlodipine Therapy in Hypertensive Outpatients, J Med Assoc Thai, Vol 93 Suppl, p 84-92.
15. Thomas Truelsen et al (2000), Global burden of cerebrovascular disease, Cerebrovascular diseases, p 1-67.
16. WHO/ISH (2003), “Statement on management of Hypertension”, Journal of Hypertesion 2003, 21(11); 1983-1992.
